Skip to main content
MarketStoryBook

Zealand Pharma A/S in 1 story

The narratives ZEAL currently appears in, with its side and exposure in each.

Bull side

1 story
  • GLP-1 Eats Everything

    ZEAL in “GLP-1 Eats Everything”

    FadingExposure: not rated yet

    Appetite suppression as a macro variable.

    Its obesity pipeline, including amylin-based petrelintide, offers direct upside from expanding demand for differentiated weight-loss medicines.

Bear side

0 stories

No bear-side stories for ZEAL yet.